Evidence map›Paper›PMID 38027927›Full record

ArticleHeliyon2023

Effect of a lifestyle intervention program's on breast cancer survivors' cardiometabolic health: Two-year follow-up.

Valentina Natalucci, Carlo Ferri Marini, Francesco Lucertini, Giosuè Annibalini, Davide Sisti, Luciana Vallorani, Roberta Saltarelli, Andrea Rocco Panico, Marta Imperio, Marco Flori and 12 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Valentina NatalucciDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Carlo Ferri MariniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Francesco LucertiniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Giosuè AnnibaliniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Davide SistiDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Luciana ValloraniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Roberta SaltarelliDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Andrea Rocco PanicoDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Marta ImperioDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Marco FloriU.O.C. Cardiologia/UTIC, AST, Ospedale Santa Maria della Misericordia, 61029, Urbino, Italy.
Paolo BusaccaU.O.C. Cardiologia/UTIC, AST, Ospedale Santa Maria della Misericordia, 61029, Urbino, Italy.
Anna VillariniDepartment of Medicine and Surgery, University of Perugia, Piazzale Settimio Gambuli, 06132, Perugia, Italy.
Sabrina Donati ZeppaDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Deborah AgostiniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Silvia MonaldiU.O.C. Oncologia Medica, AST, Ospedale Santa Maria della Misericordia, 61029, Urbino, Italy.
Simone BarocciU.O.C. Patologia Clinica, AST, Ospedale Santa Maria della Misericordia, 61029, Urbino, Italy.
Vincenzo CatalanoU.O.C. Oncologia Medica, AST, Ospedale Santa Maria della Misericordia, 61029, Urbino, Italy.
Marco Bruno Luigi RocchiDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Piero BenelliDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Vilberto StocchiDepartment of Human Sciences for the Promotion of Quality of Life, University San Raffaele, 20132, Roma, Italy.
Elena BarbieriDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Rita EmiliU.O.C. Oncologia Medica, AST, Ospedale Santa Maria della Misericordia, 61029, Urbino, Italy.
University of Urbino · ITOspedale Santa Maria · ITUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study is to assess the cardiometabolic responses of a lifestyle intervention (LI) conducted at home among breast cancer (BC) survivors during the two years of COVID-19 pandemic. A 3-month LI focused on diet and exercise was performed on thirty BC survivors (women; stages 0-II; non-metastatic; aged 53.6 ± 7.6 years; non-physically active) with a risk factor related to metabolic/endocrine diseases. Anthropometrics, cardiorespiratory fitness (

Indexed as

Aerobic exerciseBreast cancer survivorsCOVID-19Home-based lifestyle interventionMediterranean diet

Identifiers

PMID38027927
PMCPMC10651516
OpenAlexW4388011798

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.